Charu Bhatia | Jaipur | Business Remedies | April 07, 2025 |Pharmaceutical companies often grab the limelight in the healthcare sector. From COVID vaccines to weight-loss drugs, groundbreaking pharma products aim to cure the afflictions of humanity and improve quality of life. Investors are often enamoured by the promise of a potential blockbuster drug to eradicate an intractable illness, and deliver a healthy flow of profits.
Since big pharma companies rank among the largest healthcare weights, they often dominate sector positions in a global equity portfolio or a stand-alone allocation. Yet, focusing too much on pharmaceuticals could limit a portfolio’s potential. Companies that manufacture diagnostics, technology and equipment to address the world’s most pressing medical issues have become increasingly important for progress in the healthcare sector. Changes to the healthcare benchmark over the last two decades reflect this shift. The weight of pharmaceutical companies in the MSCI World Health Care Index has fallen from 82% in 2000 to 43% today. Other industries have become more prominent, offering equity investors a broader array of opportunities in areas such as life sciences tools and services, technology, and equipment.
Domains of Diagnostics and Life Sciences Tools and Services- These areas are just as important for medical processes as treatment. Advanced testing and imaging can help medical professionals detect disease at much earlier stages, improving the efficacy of treatment and chances of recovery. And the power of sequencing the human genome will unlock additional potential new drugs and help identify diseases earlier. In biotech research and development, innovative drug-development processes are enabling new treatments that can be profitable even when addressing relatively uncommon disorders.
Technology and Artificial lntelligence (AI)- Compared to other sectors, healthcare has been a laggard in our high-tech society. But things are changing. Companies that can successfully adopt new technology may be able to dramatically change the way care is provided and delivered and can be found in different parts of the sector. AI is being introduced in commercial tools by companies. As AI capabilities improve, it will become more widely used to diagnose diseases.
Equipment and Supplies From global drugmakers to your family doctor, the equipment and tools used to deliver healthcare products and services are constantly changing. Innovative equipment used in lifesaving procedures can improve outcomes for patients. For surgeons, a technological revolution is rapidly unfolding. Today, an increasing number of procedures are using robotic tools that allow surgeons to access hard-to-reach spots inside the body with high-precision, minimally invasive incisions, fewer complications and faster recovery times.
Attributes Defining Healthy Growth
While each industry has different dynamics, investors should look for three attributes to identify attractive healthcare businesses across the sector.
First, look for products and services that improve healthcare outcomes for patients. Second, companies that can help cash-strapped healthcare systems save costs are likely to benefit from strong demand drivers. Third, products that improve outcomes and save costs must generate a profit for the business.
Companies that possess these three attributes are operating in a virtuous ecosystem. The dynamics of a healthy ecosystem provide a foundation for companies to profitably reinvest cash flows, which helps support consistent earnings growth over time. Instead of having drugmakers anchor a healthcare portfolio, the starting point should be to search for high-quality business models.
Written & Edited By:
Charu Bhatia
